The Latest Cardiac and Vascular News
PRESS RELEASE REGULATED INFORMATION – INSIDE INFORMATION 15 November 2022, 07:00 am CET Data from SAHARA with first-generation DSR product (DSR 1.0) confirm: Safe, effective and rapid elimination of persistent congestion following intensive DSR therapy Considerable benefit in cardio-renal status maintained till end of study (16 weeks post-intensive DSR therapy) Dramatic and sustained improvement in diuretic response up to 15 months post […]
CardieX’s comprehensive suite of heart health solutions to be enhanced by Blumio’s next-generation cardiovascular wearable sensor algorithms and data analytics tools IRVINE, Calif., Nov. 15, 2022 /PRNewswire/ — CardieX Limited (ASX: CDX), a global health technology company focused on cardiovascular disease, today announced that it has acquired all the assets of Blumio, Inc., a Silicon Valley […]
LONG BEACH, Calif., Nov. 14, 2022 /PRNewswire/ — MemorialCare Medical Group has received the American Heart Association’s Get With The Guidelines® – Target: Type 2 DiabetesSM Gold Certificate of Recognition, as well as the American Heart Association/American Medical Association’s Get With The Guidelines® – Target BPTM Gold Plus Quality Achievement Award. The awards celebrate MemorialCare Medical Group’s commitment […]
Facility includes senior secured term loan of up to $100 million and a revolving line of credit of up to $25 million DENVER, Nov. 14, 2022 /PRNewswire/ — ViewRay, Inc. (Nasdaq: VRAY) (the “Company”) today announced that it has entered into a new five-year loan facility agreement with MidCap Financial and Silicon Valley Bank (the “Agreement”). […]
Premier members can access special pricing of Arterys’ leading medical imaging platform and clinical AI workflow solutions SAN FRANCISCO, Nov. 15, 2022 (GLOBE NEWSWIRE) — Arterys, developer of the world’s first and market-leading internet platform for medical imaging, has been awarded a national group purchasing agreement for the Artificial Intelligence […]
NEWTON, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious, rare and life-threatening diseases with significant unmet medical needs, today reported financial results for the third quarter ended September 30, 2022 and provided […]
Positive meeting with FDA provides clarity for CanGaroo® RM clearance SILVER SPRING, Md., Nov. 14, 2022 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a biologics company with a portfolio of regenerative products aimed at improving compatibility between medical devices and the patients they treat, today provided a business update and […]
Oak Ridge, TN, Nov. 15, 2022 (GLOBE NEWSWIRE) — DAXOR CORPORATION (Nasdaq: DXR) (“Daxor”, or the “Company”), the global leader in blood volume measurement technology, today announced the pricing of an underwritten public offering consisting of 210,527 shares of its common stock at a public offering price of $9.50 per share. The gross […]
— VAZKEPA® Approved in Australia to Reduce the Risk of CV Events in Adult Statin-Treated Patients with High CV Risk with Elevated Triglycerides — — Marks Fifth Regulatory Approval for VASCEPA®/VAZKEPA® Franchise in Key International Markets in 2022 — DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 15, 2022 (GLOBE NEWSWIRE) — […]
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) reports financial results for the three and nine months ended September 30, 2022 and provides a business update. On September 9, 2022, Ra Medical entered into an Agreement and Plan of Merger (the “Definitive Merger Agreement”) […]
